Some Indian pharmaceutical companies are interested in entering the Ukrainian market with Ayurveda, Yoga, Unani, Siddha and Homoeopathy (AYUSH) products, President of the Indian Pharmaceutical Manufacturers’ Association (IPMA) Dr. Ramanan Unni Parambath Menon has told Interfax-Ukraine. “Many pharmaceutical companies are present on the Ukrainian market with AYUSH products and many of them are interested in entering it,” he said, adding that the Ayurvedic term is incorrect for this segment of medications.
“AYUSH is ab abbreviation for Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy,” he said.
Commenting on the specifics of the Ukrainian regulatory base for the import of AYUSH products, Dr. Menon said that in Ukraine some of these medications are registered both as medicines and as biologically active additives.
“In India, there are separate rules for registration of AYUSH products. There are no separate rules in Ukraine. We would like these rules by analogy with India to be implemented in Ukraine,” he said.
In this case, according to Dr. Menon, some AYUSH preparations have a full package of documentation for the registration of medical products required by the State Expert Center of the Ministry of Health of Ukraine.
In turn, Head of the Representative Office of Dia Pharma Limited Ukraine Mr. Thamarai Pandian said that there are special rules of registration for AYUSH medications drawn up for the WTO in some countries like Switzerland, Germany, Hungary and some other EU countries.
“The Health Ministry of Ukraine could have introduced the same WTO rules in Ukraine,” the expert said.
At present, there are 278,000 Ayurvedic specialists, over 200 Ayurvedic educational institutions and 112 Ayurvedic skill enhancement institutions. Some 15,000 people graduate from them every year.
There are 7,439 private companies in India that produce Ayurvedic medications and over 20 companies with the international GMP certificate.
